Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Dec 11;24(6):1163–1171. doi: 10.1016/j.bbmt.2017.12.771

Table 2.

Univariate comparison of overall survival between non-HCT and auto-HCT cohorts.

Outcomes Non-HCT cohort (NLCS Dataset) Auto-HCT cohort (CIBMTR Dataset) FDR adjusted p-value
N Eval Prob (95% CI) N Eval Prob (95% CI)
Overall survival 174 175

 1-year 84 (78–89)% 88 (84–93)% 0.25

 2-year 76 (69–82)% 82 (76–88)% 0.25

 3-year 70 (63–77)% 77 (71–83)% 0.25

 5-year 60 (52–67)% 67 (60–75)% 0.25

Abbreviations: N Eval=number evaluable, Prob=probability.